Holen Sie sich die Stockscreener-App
11.11
0.18%
0.02
Schlusskurs vom Vortag:
$11.09
Offen:
$11.09
24-Stunden-Volumen:
1.62M
Relative Volume:
1.11
Marktkapitalisierung:
$790.92M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-34.98M
KGV:
-12.08
EPS:
-0.9199
Netto-Cashflow:
$-32.77M
1W Leistung:
+7.45%
1M Leistung:
+35.82%
6M Leistung:
+128.13%
1J Leistung:
+309.96%
1-Tages-Spanne:
$10.44
$11.23
1-Wochen-Bereich:
$10.04
$12.14
52-Wochen-Spanne:
$1.94
$12.14
Immix Biopharma Inc Stock (IMMX) Company Profile
Firmenname
Immix Biopharma Inc
Sektor
Branche
Telefon
(888) 958-1084
Adresse
11400 WEST OLYMPIC BLVD., LOS ANGELES
Compare IMMX vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IMMX
Immix Biopharma Inc
|
11.11 | 790.92M | 0 | -34.98M | -32.77M | -0.9199 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Immix Biopharma Inc Stock (IMMX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-25 | Eingeleitet | Morgan Stanley | Overweight |
| 2026-03-09 | Eingeleitet | Citizens | Mkt Outperform |
| 2026-02-09 | Eingeleitet | Mizuho | Outperform |
Immix Biopharma Inc Aktie (IMMX) Neueste Nachrichten
Enterprise value to revenue forward of Immix Biopharma, Inc. – NASDAQ:IMMX - TradingView
Price to book forward of Immix Biopharma, Inc. – NASDAQ:IMMX - TradingView
Immix Biopharma Inc (IMMX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Immix Biopharma, Inc. Financial Disclosures & SEC Filings - TradingView
Wall Street analysts think Immix Biopharma (IMMX) could surge 113.58%: Read this before placing a bet - MSN
IMMX News | IMMIX BIOPHARMA INC (NASDAQ:IMMX) - ChartMill
Wall Street analysts see a 120.59% upside in Immix Biopharma (IMMX): Can the stock really move this high? - MSN
Immix Biopharma, Inc.(NasdaqCM: IMMX) added to Russell 2000 Index - marketscreener.com
Immix Biopharma, Inc.(NasdaqCM: IMMX) added to Russell 2500 Growth Benchmark - marketscreener.com
Immix Biopharma, Inc.(NasdaqCM: IMMX) added to Russell 2000 Growth Benchmark - marketscreener.com
Immix Biopharma, Inc.(NasdaqCM: IMMX) added to Russell 3000E Growth Benchmark - marketscreener.com
Immix Biopharma, Inc.(NasdaqCM: IMMX) added to Russell 3000 Growth Benchmark - marketscreener.com
Immix Biopharma, Inc.(NasdaqCM:IMMX) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
Immix Biopharma (IMMX) Advances 2.67% as Biotech Momentum Builds — Key Levels in FocusNHNL Divergence - dars.gov.et
Immix Biopharma, Inc. Actuals & Estimates (NASDAQ:IMMX) - TradingView
IMMX Forecast — Price Target — Prediction for 2027 - TradingView
Immix Biopharma Inc (IMMX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Immix Biopharma analyst bullish but flags safety, adoption questions - MSN
All you need to know about Immix Biopharma (IMMX) rating upgrade to buy - MSN
All You Need to Know About Immix Biopharma (IMMX) Rating Upgrade to Buy - Yahoo Finance
Immix Biopharma (IMMX) Hovers Near Support Amid Modest Decline – Key Levels in FocusBreakout Stock Alerts - dars.gov.et
Immix Biopharma, Inc.(NasdaqCM: IMMX) added to S&P Biotechnology Select Industry Index - marketscreener.com
Immix Biopharma (IMMX) Pulls Back 4.49% – Key Support at $8.28 in FocusRounding Bottom - dars.gov.et
Immix Biopharma Analyst Bullish But Flags Safety, Adoption Questions - Benzinga
BofA initiates Immix Biopharma stock with buy rating on AL amyloidosis drug - Investing.com UK
Wall Street Analysts Think Immix Biopharma (IMMX) Could Surge 113.58%: Read This Before Placing a Bet - Yahoo Finance
Immix Biopharma, Inc. Stock 12‑Month Price Target Raised to $19.79, Implies 117% Upside - TradingView
IMMX Initiates Coverage by B of A Securities -- Rating Set to Bu - GuruFocus
This Talen Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga
BofA Securities Initiates Immix Biopharma(IMMX.US) With Buy Rating, Announces Target Price $27 - Moomoo
Immix Biopharma Inc (IMMX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Immix Biopharma Inc (IMMX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Immix Biopharma Inc (IMMX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
IMMX Initiates Coverage On LifeSci Capital -- Rating at Outperfo - GuruFocus
Immix Biopharma Inc (IMMX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Immix Biopharma Inc (IMMX) Institutional Confidence - TradingKey
Immix Biopharma Inc (IMMX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Immix Biopharma Inc (IMMX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Immix Biopharma Initiated at Outperform by LifeSci Capital - Moomoo
IMMX Q1 2026 Earnings: EPS Beat Reflects Cost Discipline Amid Pre-Revenue Biotech Pipeline ProgressProfit Guidance Range - newsline.com
IMMX Q1 2026 Earnings: Biotech Reports Narrower-than-Expected Loss, Shares GainEPS Estimate Trend - newsline.com
Immix Biopharma Surges 5.3% as Biotech Sentiment Lifts IMMXProfit Surge Picks - newsline.com
Exploring 3 High Growth Tech Stocks in the US Market - simplywall.st
What's going on with Immix Biopharma stock Thursday? - MSN
Janus Henderson files 13G/A: 9.09M shares of Immix Biopharma (IMMX) - Stock Titan
These 10 small-cap U.S. healthcare companies carry the market's most expensive valuations - Seeking Alpha
IMMX Technical Analysis | Trend, Signals & Chart Patterns | IMMIX BIOPHARMA INC (NASDAQ:IMMX) - ChartMill
Immix Biopharma, Inc. Files Form 8-K Announcing Election of Directors and Corporate Details (May 2026) - Minichart
Immix Biopharma Shareholders Back Board and Auditor at AGM - TipRanks
Immix Biopharma (NASDAQ: IMMX) posts 2026 annual shareholder voting outcomes - Stock Titan
Immix Biopharma (IMMX) awards RSUs and stock options to director Helen Adams - Stock Titan
Finanzdaten der Immix Biopharma Inc-Aktie (IMMX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Immix Biopharma Inc-Aktie (IMMX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Morris Gabriel S | CFO |
Dec 10 '25 |
Buy |
6.58 |
770 |
5,067 |
291,429 |
| Rachman Ilya M | CEO and Chairman |
Sep 17 '25 |
Buy |
2.02 |
2,500 |
5,050 |
1,140,937 |
| Morris Gabriel S | CFO |
Sep 16 '25 |
Buy |
1.97 |
2,600 |
5,122 |
290,659 |
2.64%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):